Keywords: zeneca, loses, bid, block, generic, propofol, subsidiary

Zeneca loses bid to block generic propofol

Article | 30 March 1999

Print This

Zeneca's US subsidiary, Zeneca Inc, has been blocked in its bid to getthe US Food and Drug Administration to rescind ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in